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16STUDY PROTOCOL Open AccessThe InterHerz project - a web-based
psychological treatment for cardiac patients with
depression: study protocol of a randomized
controlled trial
Nadine Messerli-Bürgy1*, Jürgen Barth2 and Thomas Berger1Abstract
Background: Patients with heart disease often suffer from difficulties in psychological adaptation during cardiac
rehabilitation. Mood disorders such as depression are known to be highly prevalent in cardiac patients and to have
a negative impact on the progression of coronary heart disease. However, cardiac patients have difficulties to get
psychological treatments due to low availability and motivational difficulties. Web-based interventions have been
proven to be effective in treating depressive symptoms. Deprexis is a promising web-based psychological
treatment which was devised for depressed patients. The aim of the study InterHerz is to examine if Deprexis is an
effective psychological treatment to reduce stress and depression in cardiac patients.
Methods/Design: The sample will consist of 80 depressed patients randomized to an intervention group or a
waitlist (10 weeks). Patients are recruited via cardiologists, cardiac rehabilitation units and the website of the Swiss
Heart Foundation. Patients have access to a guided self-help program in which they work themselves through
several modules and receive feedback from a clinical psychologist. Pre- and post-assessments, and a six-month
follow-up, are conducted using online questionnaires and diagnostic interviews.
Discussion: Deprexis is a new web-based treatment which has the potential to help depressed cardiac patients
with limited access to psychological treatment to increase their mental health.
Trial registration: Current Controlled Trials ISRCTN45945396
Keywords: Psychological treatment, Web-based, Depression, Guided self-help, Heart disease, Randomized
controlled trialBackground
There is a large body of evidence that high or prolonged
stress, depression and low social support are predictive of
coronary artery health [1-4]. In particular, depression has
been identified as a psychosocial factor with enormous
potential to influence the course and outcome of coronary
artery disease [3,5,6]. Despite the empirical evidence that
depression increases the risk of cardiovascular morbidity
and mortality itself, there is no common accepted model
that describes the underlying mechanisms [7,8]. Both* Correspondence: nadine.messerli@psy.unibe.ch
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distribution, and reproduction in any mediumdirect and indirect pathways have been put forward. On
one hand, direct influences of depression on physiological
factors may lead to atherosclerosis or coronary events. On
the other hand, depression leads to an increase in coro-
nary risk factors (that is, inflammation), which in turn
may cause heart disease. Finally, there may be some
underlying factors (that is, distress, personality, social
environment and health behavior) influencing the risk for
both depression and heart disease [9]. Psychosocial and
behavioral factors correlate both with depression and
heart disease. Depression is associated with poor health
behavior, maladaptive coping style, social isolation, and
chronic life stress [10]. Behavioral risk factors, such as
smoking, low physical activity, a poor diet, and the failureCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tionship of depressive disorders with heart disease [11,12].
Several studies have focused on the treatment of depres-
sive symptoms in cardiac patients. The study, enhancing
recovery in coronary heart disease patients with depres-
sion (ENRICHD), examined the efficacy of psychotherapy
(cognitive-behavioral approach) on depression [13]. The
effect size (ES) of short-term efficacy in comparison to the
control group were small (ES = 0.35), and disappeared on
long-term follow-up. Furthermore, the Canadian cardiac
randomized evaluation of antidepressant and psychother-
apy efficacy (CREATE) study, investigating the benefit of an
interpersonal psychotherapy (IPT) [14], only detected a ten-
dency towards a reduced depression level in the IPT group
compared to the non-treated group (ES = 0.20). Larger ES
over 0.70 were reported for psychotherapy in depressed but
otherwise healthy people. However, these effects might be
overestimated due to publication bias [15].
One of the greatest challenges of a psychotherapeutic
approach to support treatment success of cardiac patients
with depression is the time and resource intensity of most
traditional approaches of treatment delivery. The oppor-
tunity to develop new forms of intervention, for example,
web-based treatment, has never been more feasible. To
date, there is sparse evidence that psychotherapy influ-
ences the progress of heart disease.
Many people are now web-literate and many have
access to the Internet. Today, internet-based technolo-
gies are used at almost all levels of psychosocial services.
Apart from possible cost-effectiveness and the fact that
web-based interventions can flexibly be used indepen-
dently of time and place, a major advantage of the web-
based approach is that it offers support to people who
may not otherwise seek or reach treatment.
Over recent years, web-based treatments have been
used with success to promote health [16,17] and have
shown promising outcomes for several psychiatric condi-
tions, including depression [18-20]. Particularly web-based
guided self-help approaches, in which the presentation
of a web-based self-help program is combined with
minimal but regular therapist contact via e-mail, have
shown promising results. Emerging evidence from
meta-analyses [19,21] and from a reanalysis of data
across trials [22] suggests a superiority of guided versus
unguided self-help, both in terms of efficacy and drop-
out rates.
There are only a few web-based interventions for
cardiac patients that have been developed and evaluated
so far [23]. Preliminary results confirm that a web-based
intervention for cardiac patients can help to change psy-
chosocial risk factors. Web-based interventions can reduce
symptoms of depression [24,25] and anxiety [25,26] and
help to increase social support [27]. Besides this, cardiac
patients report improvements in managing their physicalcondition by knowing more about their disease, and there-
fore increase their perception of control [28] and change
their health behavior [29,30]. In addition, improvements
in quality of life [27,31,32], and even improvements in
adherence due to the presentation of a cardiac-specific
information tool [25,33] have been reported.
There are only two web-based psychological treatment
programs to have been developed so far: a specific web-
based distress management program for patients with
cardioverter defibrillator [34] and a web-based treatment
for cardiac patients with depression [35].
In consideration of the difficulties of treating cardiac
patients, this intervention study InterHerz strikes a new
path by implementing a proven and promising web-
based approach called Deprexis in a somatically ill
patient group with depression [36-38]. Deprexis has
been developed to reduce depressive symptoms in phys-
ically healthy patients with a depressive disorder. To
our knowledge, this is the only psychological treatment
for German-speaking patients with depression, and in
contrast to other web-based tools, it integrates different
psychotherapeutic approaches [36].
Methods/Design
Aims
The primary aim of InterHerz is to investigate whether
the proven web-based treatment Deprexis is effective to
reduce depression and perceived stress in cardiac patients.
Secondary aims are to examine the mid-term effects of
Deprexis on depression, perception of stress, social sup-
port, and changes in health behavior after six months
follow-up.
Design
The study uses a randomized controlled design comparing
a web-based treatment with a waitlist control condition.
All patients in the treatment group receive basic informa-
tion on the use of the program, a booklet on depression
and heart disease, a personal user name and a password.
They have immediate access to the program. Patients
under the waitlist condition receive the equivalent access
to the program after a waiting period of 10 weeks. The
randomization sequence is generated by the website
Research Randomizer ([http://www.randomizer.org]) and
concealed in the study center of the Institute for Social
and Preventive Medicine, University of Bern (Switzerland).
Sample size calculation
In a previous study testing the same psychological treat-
ment in depressed patients, medium to large between-
group effect sizes were found [37]. Assuming medium
between-group effects, 80 randomized patients in total
(40 patients per treatment condition) are needed in this
study. This estimation is based on the assumptions of a
Messerli-Bürgy et al. Trials 2012, 13:245 Page 3 of 7
http://www.trialsjournal.com/content/13/1/245level of significance of 0.05 (two-sided), 80% statistical
power (1-Beta), and correlations between pre- and post-
assessment found in previous studies, and the estimate
was calculated using G-Power [39].Study sample
Patients with any coronary artery disease are invited to
participate in the study. We estimate a number of more
than 2,000 patients who shall be reached through the col-
laborating cardiology institutions (for example, rehabilita-
tion centers, hospitals). The Swiss Heart Foundation and
the Swiss Association of Cardiovascular Prevention and
Rehabilitation support the project through advertisement
of the InterHerz study on their website and through the
distribution of flyers. Assuming more than 2,000 patients
will be informed about our web-based intervention, we
expect about 300 patients to show initial interest via email.
According to our earlier research on web-based interven-
tions, about half of the patients who initially show interest
and contact us will give their written consent and fill out
the screening questionnaires (n = 150). After a clinical
interview and the application of inclusion criteria we
expect a total number of 80 patients to be randomized to
the two treatment conditions (for details see the flow chart
in Figure 1).Initial information (N= ca. 2000)
Depressed participants (N=80)
Intervention (N=40)
Randomization
Waiting list (
Meet all inclusion criteria (N=100)
Apply to participate via email (N=300
Complete diagnostic interview (DISH) 
assessment of inclusion criteria (N=15
Informed consent and fill in questionnai
including screening for depression (BDI) (N
Interventi
Figure 1 Recruitment and participant flow.Inclusion and exclusion criteria
Adults who suffer from any cardiovascular disorder
(including coronary heart disease, chronic heart failure,
and arrhythmias) can apply to participate. Patients are
included if they return the informed consent, are 18
years or older, have symptoms of depression (as defined
by scoring above a cut-off of 9 on the Beck Depression
Inventory (BDI-II)), are of sufficient knowledge of
German language, and have access to the Internet. If
patients have any acute health threatening disease
(for example, cancer), a severe psychiatric illness (for
example, psychosis, dementia), suicidal thoughts or
plans, or an unstable heart condition, they are excluded
from the study. Participants will remain in the study in
case of further progression of heart disease during study
participation.Intervention
The intervention is a web-based psychological treatment
called Deprexis, which has been evaluated in previous
trials [8] ([http://www.deprexis.de]). Deprexis was devel-
oped to reduce depressive symptoms in patients who do
not have any somatic disease. The treatment consists of
10 content modules. All modules can each be completed
in 10 to 60 minutes, depending on the user’s readingExcluded (below cut-
off for depression 
BDI<10)
N=40)
)
Not interested 
(N= ca.1700)
and 
0)
res 
=200)
Excluded for clinical 
reasons (N=50)
Do not send informed 
consent (N=100)
Early drop-outs 
(N=20)
on
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the program. The modules are organized as simulated
dialogues in which the program explains and illustrates
concepts and techniques, engages the user in exercises,
and continuously asks users to respond by selecting
from response options. Subsequent content is then
tailored to the users’ responses, resulting in a simulated
conversational flow. The modules cover a variety of
therapeutic content that is broadly consistent with a
cognitive-behavioral perspective, although the program
is not restricted to one cognitive behavioral therapy
(CBT) manual. Instead, an effort was made to design the
program as an integrative treatment tool that provides a
variety of relevant therapeutic approaches and fits within
the broad array of contemporary CBT (see Table 1). The
link to the website of the InterHerz study is provided from
the applicant’s institution ([https://www.online-therapy.ch/
interherz]).
During their work through Deprexis, participants are
guided by a clinical psychologist. Weekly feedback on
patient’s work and progress are given via an integrated
email system. Participants are able to contact the psy-
chologist via email if they have any questions during the
intervention period.
Assessment
The efficacy of the intervention is assessed post-treatment
(T2) and additionally at 6 months follow-up (T3). Pre-
treatment assessment (T0) is conducted by a psychologist
before the randomization procedure to assess the level
of depression, and to collect information on perceived
stress, perceived social support and quality of life. At
baseline, we further assess medical information on the
disease, duration of the disease, time of the event, risk
behavior (for example, smoking, low physical activity,
poor diet), and medication or other psychotherapeutic
treatments. Moreover, a clinical diagnostic interview is
conducted by phone. To address the research question,Table 1 Components included in the psychological
treatment Deprexis
Number Component
1 Behavioral activation
2 Cognitive modification
3 Mindfulness and acceptance
4 Interpersonal skills
5 Relaxation, physical exercise and lifestyle modification
6 Problem solving
7 Childhood experiences and early schemas
8 Positive psychology interventions
9 Dreamwork and emotion-focused interventions
10 Psychoeducationdepression levels are measured during treatment (T1),
and treatment satisfaction is measured at the end of
the treatment (T2).
Measures
The German version of the Beck Depression Inventory
(BDI-II) [40] is administered to assess the level of
depressive symptoms. Ten points or more is to be con-
sidered a clinically relevant score for depressive symp-
tomatology. All patients with depressive symptoms
above this cut off are asked to fill out the German ver-
sion of the Patient Health Questionnaire (PHQ-D) [41]
and are additionally interviewed by a psychologist with
the Structured Clinical Interview for DSM diagnosis
(SCID) to classify patients as clinically depressed accord-
ing to the American Psychiatric Association Diagnostic
and Statistical Manual [42]. Stress perception is assessed
by the Perceived Stress Questionnaire PSQ [43] and
perceived social support by the German version of the
self-rated 7-item ENRICHD Social Support Inventory
(ESSI) [44]. The World Health Organization (WHO)
quality of life-BREF (WHOQOL-BREF) (German ver-
sion) [45], a brief form of a transcultural quality of life
assessment instrument developed by the WHO, is used
to measure quality of life. Client satisfaction is assessed
post-treatment with the German version of the Client
Satisfaction Questionnaire (CSQ) [46]. Medication and
compliance with medication are assessed by free text
and health-related lifestyle (for example smoking, phys-
ical activity, diet) with dichotomous items in line with
earlier studies by the research team [47].
Ethics considerations
The study protocol was approved by the Local Ethical
Committee of the Faculty of Human Sciences, University
of Bern and is in accordance with the Declaration of
Helsinki. All patients receive written information about
the aim of the study, benefits and risks of participation
and the exact study procedure before giving their written
informed consent to participate in the study. At that
time all participants are informed that they can cancel
participation without disclosing any reason at any time
during the study.
With each participant an individual emergency plan is
developed at the beginning of the study via a personal
call. They receive information on nearby facilities in case
of an emotional crisis (crisis intervention ward, psychi-
atric emergency units). In addition, an emergency link
on the homepage provides telephone numbers and sev-
eral addresses of treatment institutions that can be con-
tacted 24 h a day. Patients with a suicidal tendency are
excluded from the study. They are informed that a web-
based intervention is not an appropriate treatment for
patients in emotional crisis and are asked to seek help
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of these settings.
Statistical analyses
We will analyse the longitudinal data according to a com-
pleter analysis (after the intervention) and in addition we
will use intent-to-treat analysis including patients who
drop out during the intervention or waiting period. The
efficacy of the intervention will be estimated using analysis
of variance with baseline values as covariates and add-
itional assessments conducted after 5 sessions (midterm)
and after 10 sessions (post). The primary endpoint will be
depressive symptoms measured by BDI II and a diagnostic
interview after 10 weeks. Secondary end points will be
perception of stress, social support, quality of life and
compliance. Long-term stability of the efficacy of the
intervention will be analysed by comparisons of pre-
treatment and follow-up assessments of depression in all
participants (InterHerz and waitlist control group) using
the t-test of dependent samples, and pre-treatment to
follow-up effect sizes will be calculated. For the prediction
of treatment success we will use clinical variables (for
example, severity of cardiac disease), sociodemographic
variables (for example, age, gender) and process measures
(for example, working alliance). Since missing values are a
critical issue in longitudinal studies we will use a statistical
algorithm for the estimation of missing values as imple-
mented in SPSS.
Discussion
This study examines the efficacy of a web-based, guided
self-help treatment for depressed cardiac patients in
terms of depressive symptoms, perception of stress,
social support, quality of life and health behavior change.
So far, no randomized controlled trial exists that specif-
ically evaluates the efficacy of a web-based psychological
treatment for cardiac patients with depressive symptoms.
Given the fact that cardiac patients have limited access
to psychological treatments, it is important to know
whether such an easily accessible and low-cost interven-
tion has future potential to be an integrative part in the
rehabilitation of cardiac patients and in the general
health system.
As patients with heart disease will be on average a
relatively old patient group, we asked patients in a
cardiac rehabilitation unit about the use of the Internet
for health-related information as part of our preparation
of the study protocol. In a sample of 59 patients (mean
age 67 yrs, SD 8.6) 71% of the cardiac patients reported
that they had their own access to the Internet and would
use it as a source for health-relevant information on a
regular basis. Furthermore, over 80% expressed interest
in using a new web-based intervention. Whether these
patients would benefit from a web-based psychologicaltreatment specifically developed for depression remains
unclear.
There are limitations to the study design. First, the
intervention is not specifically adapted for cardiac
patients and the effect on cardiac health will not be in
the main focus of the investigation. Second, participants
of the waitlist receive access to the psychological treat-
ment after a delay of ten weeks, therefore, we will not be
able to compare groups at the 6-month follow-up.
The study has several strengths. It has a high external
validity since patients are recruited from cardiology
institutions and organizations, and since patients suffer-
ing from various cardiovascular disorders are included.
Depression is assessed by self-rated instruments and a
diagnostic interview. This allows more profound know-
ledge of the actual mental state of the participant.
Furthermore, to our knowledge this is the first web-
based psychological treatment for cardiac patients using
a proven web-based depression tool. This investigation
will allow us to extend our knowledge of the benefits
and limits of a web-based psychological treatment that
integrates the most recent treatment approaches for
depressed cardiac patients.
Trial status
Recruitment of participants is ongoing; it began in
March 2012 and is expected to end in June 2013.
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